The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis
- PMID: 15785046
- DOI: 10.1159/000083509
The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis
Abstract
Background: Chronic plaque-type psoriasis is a major dermatosis, but a significant question is still unanswered: What defines severity in chronic plaque-type psoriasis? While objective assessments like the Psoriasis Area and Severity Index (PASI) have frequently been used in clinical trials, quality of life (QOL) questionnaires are currently becoming more and more popular.
Objective: This article summarizes the most important objective and subjective measurements of severity in psoriasis. For every dermatologist it is critically important to distinguish between severe psoriasis and psoriasis that severely affects QOL. Even if the PASI also has disadvantages, it is the most adequate instrument available to evaluate severity in plaque-type psoriasis.
Result: We provide reasons why PASI >12 defines severe, PASI 7-12 moderate and PASI <7 mild chronic plaque-type psoriasis.
Comment in
-
A new era in the management of psoriasis? Promises and facts.Dermatology. 2005;210(3):179-81. doi: 10.1159/000083505. Dermatology. 2005. PMID: 15785042
Similar articles
-
A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index.Br J Dermatol. 2008 Aug;159(2):407-12. doi: 10.1111/j.1365-2133.2008.08680.x. Epub 2008 Jun 28. Br J Dermatol. 2008. PMID: 18565187
-
Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased.Br J Dermatol. 2004 Aug;151(2):381-7. doi: 10.1111/j.1365-2133.2004.06035.x. Br J Dermatol. 2004. PMID: 15327545
-
A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment.Br J Dermatol. 2006 Oct;155(4):707-13. doi: 10.1111/j.1365-2133.2006.07389.x. Br J Dermatol. 2006. PMID: 16965419 Clinical Trial.
-
The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab.Arch Dermatol Res. 2008 Nov;300(10):537-44. doi: 10.1007/s00403-008-0885-7. Epub 2008 Sep 11. Arch Dermatol Res. 2008. PMID: 18784934 Review.
-
The skin in psoriasis: assessment and challenges.Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S14-9. Epub 2015 Oct 15. Clin Exp Rheumatol. 2015. PMID: 26472560 Review.
Cited by
-
Increased risk of atrial and ventricular arrhythmia in long-lasting psoriasis patients.ScientificWorldJournal. 2013 Apr 3;2013:901215. doi: 10.1155/2013/901215. Print 2013. ScientificWorldJournal. 2013. PMID: 23653531 Free PMC article.
-
The Effect of Three-Month Vitamin D Supplementation on the Levels of Homocysteine Metabolism Markers and Inflammatory Cytokines in Sera of Psoriatic Patients.Biomolecules. 2021 Dec 11;11(12):1865. doi: 10.3390/biom11121865. Biomolecules. 2021. PMID: 34944509 Free PMC article.
-
Factors associated with quality of life in Chinese people with psoriasis: a cross-sectional study.BMC Public Health. 2023 Sep 25;23(1):1860. doi: 10.1186/s12889-023-16758-6. BMC Public Health. 2023. PMID: 37749489 Free PMC article.
-
Atrial electromechanical delay is impaired in patients with psoriasis.Med Princ Pract. 2015;24(1):30-5. doi: 10.1159/000365760. Epub 2014 Aug 19. Med Princ Pract. 2015. PMID: 25138738 Free PMC article.
-
[Depression and anxiety in patients with psoriatic arthritis: Prevalence and associated factors].Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Dec 18;52(6):1048-1055. doi: 10.19723/j.issn.1671-167X.2020.06.010. Beijing Da Xue Xue Bao Yi Xue Ban. 2020. PMID: 33331312 Free PMC article. Chinese.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
